Wall Street Zen lowered shares of AdaptHealth (NASDAQ:AHCO – Free Report) from a buy rating to a hold rating in a report published on Saturday.
AHCO has been the subject of a number of other reports. Robert W. Baird set a $10.00 target price on AdaptHealth in a research report on Wednesday, August 5th. Truist Financial cut their price target on AdaptHealth from $14.00 to $9.00 and set a “buy” rating on the stock in a research report on Wednesday, August 5th. Weiss Ratings reiterated a “sell (d)” rating on shares of AdaptHealth in a research note on Friday, May 22nd. UBS Group decreased their price objective on AdaptHealth from $14.00 to $10.00 and set a “buy” rating for the company in a report on Thursday. Finally, Jefferies Financial Group raised AdaptHealth from a “hold” rating to a “buy” rating and increased their price objective for the company from $11.00 to $13.00 in a report on Tuesday, July 21st. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $10.29.
View Our Latest Report on AHCO
AdaptHealth Stock Performance
Insider Activity
In related news, insider Russell E. Schuster III sold 11,275 shares of the business’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the transaction, the insider owned 136,538 shares in the company, valued at $1,373,572.28. The trade was a 7.63% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Kenneth A. Samet acquired 23,500 shares of AdaptHealth stock in a transaction on Thursday, August 6th. The shares were bought at an average cost of $6.38 per share, with a total value of $149,930.00. Following the completion of the purchase, the director owned 48,569 shares in the company, valued at $309,870.22. The trade was a 93.74% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.95% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of AdaptHealth by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 11,768,599 shares of the company’s stock worth $117,215,000 after purchasing an additional 491,106 shares during the period. Deerfield Management Company L.P. increased its stake in AdaptHealth by 15.9% in the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock valued at $102,726,000 after buying an additional 1,572,835 shares during the period. Reinhart Partners LLC. increased its stake in AdaptHealth by 10.6% in the 4th quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock valued at $80,684,000 after buying an additional 773,727 shares during the period. Dimensional Fund Advisors LP raised its position in AdaptHealth by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock worth $82,353,000 after buying an additional 518,274 shares during the last quarter. Finally, Principal Financial Group Inc. raised its position in AdaptHealth by 25.1% during the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock worth $33,133,000 after buying an additional 558,357 shares during the last quarter. Institutional investors and hedge funds own 82.67% of the company’s stock.
About AdaptHealth
AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.
The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.
Featured Articles
- Five stocks we like better than AdaptHealth
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.
